Twist Bioscience Future Growth
How is Twist Bioscience forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
6.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2025 | 428 | -192 | -104 | -76 | 5 |
9/30/2024 | 345 | -218 | -150 | -109 | 7 |
9/30/2023 | 266 | -260 | -210 | -160 | 8 |
9/30/2022 | 204 | -218 | -226 | -124 | N/A |
6/30/2022 | 184 | -208 | -251 | -158 | N/A |
3/31/2022 | 163 | -188 | -212 | -152 | N/A |
12/31/2021 | 146 | -165 | -170 | -134 | N/A |
9/30/2021 | 132 | -152 | -139 | -112 | N/A |
6/30/2021 | 127 | -135 | -124 | -103 | N/A |
3/31/2021 | 113 | -123 | -115 | -98 | N/A |
12/31/2020 | 101 | -117 | -144 | -132 | N/A |
9/30/2020 | 90 | -140 | -152 | -142 | N/A |
6/30/2020 | 73 | -147 | -152 | -140 | N/A |
3/31/2020 | 66 | -147 | -153 | -139 | N/A |
12/31/2019 | 60 | -141 | -116 | -101 | N/A |
9/30/2019 | 54 | -108 | -103 | -88 | N/A |
6/30/2019 | 47 | -96 | -93 | -81 | N/A |
3/31/2019 | 40 | -86 | -84 | -76 | N/A |
12/31/2018 | 33 | -77 | -76 | -72 | N/A |
9/30/2018 | 25 | -71 | -70 | -66 | N/A |
6/30/2018 | 20 | -68 | -67 | -61 | N/A |
9/30/2017 | 11 | -59 | -58 | -51 | N/A |
9/30/2016 | 2 | -44 | -45 | -39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TWST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TWST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TWST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TWST's revenue (24.1% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: TWST's revenue (24.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TWST is forecast to be unprofitable in 3 years.